Manchester Capital Management LLC - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 90 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Manchester Capital Management LLC ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$16,000
-23.8%
3,2390.0%0.00%
-33.3%
Q2 2021$21,000
-16.0%
3,2390.0%0.00%
-25.0%
Q1 2021$25,000
+19.0%
3,2390.0%0.00%
+33.3%
Q4 2020$21,000
-4.5%
3,2390.0%0.00%0.0%
Q3 2020$22,000
-18.5%
3,2390.0%0.00%
-25.0%
Q2 2020$27,000
+8.0%
3,2390.0%0.00%0.0%
Q1 2020$25,000
-7.4%
3,2390.0%0.00%
+33.3%
Q4 2019$27,000
+12.5%
3,2390.0%0.00%0.0%
Q3 2019$24,000
-33.3%
3,2390.0%0.00%
-40.0%
Q2 2019$36,000
+2.9%
3,2390.0%0.01%
+25.0%
Q1 2019$35,000
-52.7%
3,2390.0%0.00%
-63.6%
Q4 2018$74,000
+23.3%
3,2390.0%0.01%
+22.2%
Q3 2018$60,000
-18.9%
3,2390.0%0.01%
-18.2%
Q2 2018$74,000
-19.6%
3,2390.0%0.01%
-26.7%
Q1 2018$92,000
+35.3%
3,2390.0%0.02%
+50.0%
Q4 2017$68,000
+15.3%
3,2390.0%0.01%
+11.1%
Q3 2017$59,000
+18.0%
3,2390.0%0.01%
+12.5%
Q2 2017$50,000
-10.7%
3,2390.0%0.01%
-11.1%
Q1 2017$56,000
+55.6%
3,2390.0%0.01%
+80.0%
Q4 2016$36,000
-29.4%
3,2390.0%0.01%
-37.5%
Q3 2016$51,000
+54.5%
3,2390.0%0.01%
+60.0%
Q2 2016$33,0003,2390.01%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Burrage Capital Management LLC 476,110$3,956,0002.65%
MPM BioImpact LLC 855,437$7,109,0002.52%
Exane Asset Management 87,876$730,250,0000.90%
Congress Park Capital LLC 94,661$787,0000.58%
Perceptive Advisors 3,253,923$27,040,0000.54%
BVF INC/IL 766,148$6,367,0000.48%
RTW INVESTMENTS, LP 1,039,593$8,639,0000.33%
EcoR1 Capital, LLC 410,000$3,407,0000.31%
DAFNA Capital Management LLC 100,000$831,0000.28%
HARBOURVEST PARTNERS LLC 79,193$658,0000.27%
View complete list of CYTOMX THERAPEUTICS INC shareholders